CS235196B1 - Method of 4,9-dihydro-3,9-dimethyl-4-oxo-1h-pyrazolo(3,4-b) quinoline - Google Patents

Method of 4,9-dihydro-3,9-dimethyl-4-oxo-1h-pyrazolo(3,4-b) quinoline Download PDF

Info

Publication number
CS235196B1
CS235196B1 CS841307A CS130784A CS235196B1 CS 235196 B1 CS235196 B1 CS 235196B1 CS 841307 A CS841307 A CS 841307A CS 130784 A CS130784 A CS 130784A CS 235196 B1 CS235196 B1 CS 235196B1
Authority
CS
Czechoslovakia
Prior art keywords
dihydro
oxo
pyrazolo
quinoline
dimethyl
Prior art date
Application number
CS841307A
Other languages
Czech (cs)
Inventor
Viktor Zikan
Stanislav Radl
Original Assignee
Viktor Zikan
Stanislav Radl
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Priority claimed from CS838460A external-priority patent/CS235183B1/en
Application filed by Viktor Zikan, Stanislav Radl filed Critical Viktor Zikan
Priority to CS841307A priority Critical patent/CS235196B1/en
Publication of CS235196B1 publication Critical patent/CS235196B1/en

Links

Landscapes

  • Nitrogen Condensed Heterocyclic Rings (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)

Abstract

Vynález se týká nového způsobu přípravy 4,9-dihydro-3,9-dimethyl-4-oxo-lH-pyrazolo- (3,4-bjohinolinu, vyznačujícího se tím, že se zahřívá 4,9-dihydro-2,3,9-trimethyl-4-oxo-2H- -pyrazolo[ 3,4-b ] chinolin s hydrochloridem pyridinu na teplotu 200 až 240 °C, výhodně na teplotu 220 °C.The present invention relates to a new method of preparation 4,9-dihydro-3,9-dimethyl-4-oxo-1H-pyrazolo- (3,4-binoquinoline) heats 4,9-dihydro-2,3,9-trimethyl-4-oxo-2H- -pyrazolo [3,4-b] quinoline with hydrochloride pyridine to a temperature of 200 to 240 ° C, preferably at 220 ° C.

Description

Vynález se týká nového způsobu přípravyThe invention relates to a novel preparation process

4,9-dihydro-3,9-dimethyl-4-oxo-lH-pyrazolo[3,4-b]chinolinu vzorce I4,9-Dihydro-3,9-dimethyl-4-oxo-1H-pyrazolo [3,4-b] quinoline of Formula I

Uvedená sloučenina vzorce I slouží jako meziprodukt pro přípravu biologicky významných látek, zejména s protivirovým účinkem.Said compound of formula (I) serves as an intermediate for the preparation of biologically important substances, in particular having antiviral activity.

Uvedená sloučenina vzorce I je známá látka, je popsána její příprava, vyznačující se tím, že se zahřívá 4-(2-fluorfenyl-6,3-dihydro-l,3,8-trimethylpyrazolo (3,4-e )(1,4) diazepin-7(lH)on s hydrochloridem pyridinu na teplotu 210 až 215 °C [DeWald H. A.; J. Heterocyclic Chem. 11, 1061 (1974)].Said compound of formula (I) is a known substance, the preparation of which is characterized by heating 4- (2-fluorophenyl-6,3-dihydro-1,3,8-trimethylpyrazolo (3,4-e) (1, 2-fluorophenyl)). 4) diazepin-7 (1H) on with pyridine hydrochloride at 210-215 ° C [DeWald HA; J. Heterocyclic Chem. 11, 1061 (1974)].

Uvedená sloučenina vzorce I byla připravena způsobem podle vynálezu, vyznačující se tím, že se zahřívá 4,9-dihydro-2,3,9-trimethyl-4-oxo-2H-pyrazolo (3,4-b) chinolin (čs. autorské osvědčení č. 235 168 s hydrochloridem pyridinu při teplotě 200 až 240 °C, výhodně při teplotě 220 °C.Said compound of formula (I) was prepared by the process of the invention, characterized by heating 4,9-dihydro-2,3,9-trimethyl-4-oxo-2H-pyrazolo (3,4-b) quinoline (U.S. Pat. No. 235 168 with pyridine hydrochloride at a temperature of 200 to 240 ° C, preferably at a temperature of 220 ° C.

Vzhledem ke snadné připravitelnosti výchozího 4,9-dlhydro-2,3,9-trimethyl-4-oxo-2H-pyrazolof 3,4-b) chinolinu (čs. autorské osvědčení čís. 235168), a vzhledem k obtížné přípravě 4- (2-fluorfenyl)6,8-dihydro-l,3,8-trimethylpyrazolo[ 3,4-e] ((l,4]diazepin-7(lH)onu, je zřejmá výhodnost přípravy sloučeniny vzorce I podle vynálezu.Given the ease of preparation of the starting 4,9-dlhydro-2,3,9-trimethyl-4-oxo-2H-pyrazolof 3,4-b) quinoline (cf. No. 235168), and the difficult preparation of 4- (2-fluorophenyl) 6,8-dihydro-1,3,8-trimethylpyrazolo [3,4-e] ((1,4) diazepin-7 (1H) -one), the advantageous preparation of the compound of formula I of the invention is evident.

Následující příklad provedení vynález dokládá, ale nikterak neomezuje.The following exemplary embodiment illustrates the invention but does not limit it in any way.

PříkladExample

4,9-Dihydro-3,9-dimethyl-4-oxo-lH-pyrazolo [ 3,4-b ] chinolin > Z míchané směsi 30 g pyridinu a 44 ml koncentrované kyseliny chlorovodíkové byla postupným zvyšováním teploty na 160 °C oddestilována voda. Při této teplotě bylo přidáno 3,2 g 4,9-dihydro-2,3,9-trimethyl-4-oxo-2H-pyrazolo[ 3,4-b] chinolin a směs byla míchána 2 hodiny při teplotě 220 °C. Po ochlazení na 160 °C byla směs nalita do 240 ml vody, směs byla povařena a nerozpustný podíl byl odfiltrován. Látka vyloučená po ochlazení filtrátu byla odsáta a promyta vodou. Krystaly získané krystalizací z ethanolu byly sušeny do konstantní hmotnosti při teplotě 110 °C za tlaku 3 kPa. Bylo získáno 2,32 g látky (77,7 %) o t. t. 248,8 až 249,5 °C.4,9-Dihydro-3,9-dimethyl-4-oxo-1H-pyrazolo [3,4-b] quinoline Water was distilled from a stirred mixture of 30 g of pyridine and 44 ml of concentrated hydrochloric acid by gradually increasing the temperature to 160 ° C. . At this temperature, 3.2 g of 4,9-dihydro-2,3,9-trimethyl-4-oxo-2H-pyrazolo [3,4-b] quinoline was added and the mixture was stirred at 220 ° C for 2 hours. After cooling to 160 ° C, the mixture was poured into 240 ml of water, the mixture was boiled and the insoluble matter was filtered off. The precipitate upon cooling of the filtrate was aspirated and washed with water. Crystals obtained by crystallization from ethanol were dried to constant weight at 110 ° C at 3 kPa. 2.32 g (77.7%) of m.p. 248.8-249.5 ° C were obtained.

Claims (1)

Způsob přípravy 4,9-dihydro-3,9-dimethyl-4-oxo-lH-pyrazolo [ 3,4-b ] chinolinu, vyznačující se tím, že se zahřívá 4,9-dihydro-2,3,9-trimethyl-4-oxo-2H-pyrazolo [3,4-b ] chinolin s hydrochloridem pyridinu pře teplotě 200 až 240 °C, výhodně při telotě 220 °C.A process for the preparation of 4,9-dihydro-3,9-dimethyl-4-oxo-1H-pyrazolo [3,4-b] quinoline, characterized by heating 4,9-dihydro-2,3,9-trimethyl -4-oxo-2H-pyrazolo [3,4-b] quinoline with pyridine hydrochloride at a temperature of 200 to 240 ° C, preferably at a temperature of 220 ° C.
CS841307A 1983-11-15 1984-02-24 Method of 4,9-dihydro-3,9-dimethyl-4-oxo-1h-pyrazolo(3,4-b) quinoline CS235196B1 (en)

Priority Applications (1)

Application Number Priority Date Filing Date Title
CS841307A CS235196B1 (en) 1983-11-15 1984-02-24 Method of 4,9-dihydro-3,9-dimethyl-4-oxo-1h-pyrazolo(3,4-b) quinoline

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
CS838460A CS235183B1 (en) 1983-09-09 1983-11-15 Method of 4,9-dihydro-3,9-dimethyl-4-oxo-1h-pyrazolo-(3,4-b)quinoline preparation
CS841307A CS235196B1 (en) 1983-11-15 1984-02-24 Method of 4,9-dihydro-3,9-dimethyl-4-oxo-1h-pyrazolo(3,4-b) quinoline

Publications (1)

Publication Number Publication Date
CS235196B1 true CS235196B1 (en) 1985-05-15

Family

ID=5435137

Family Applications (2)

Application Number Title Priority Date Filing Date
CS841307A CS235196B1 (en) 1983-11-15 1984-02-24 Method of 4,9-dihydro-3,9-dimethyl-4-oxo-1h-pyrazolo(3,4-b) quinoline
CS841308A CS235197B1 (en) 1983-11-15 1984-02-24 Method of 4,9-dihydro-3,9-dimethyl-4-oxo-1h-pyrazolo (3-4-b) quinoline preparation

Family Applications After (1)

Application Number Title Priority Date Filing Date
CS841308A CS235197B1 (en) 1983-11-15 1984-02-24 Method of 4,9-dihydro-3,9-dimethyl-4-oxo-1h-pyrazolo (3-4-b) quinoline preparation

Country Status (1)

Country Link
CS (2) CS235196B1 (en)

Also Published As

Publication number Publication date
CS235197B1 (en) 1985-05-15

Similar Documents

Publication Publication Date Title
JPH0148911B2 (en)
SU475768A3 (en) The method of obtaining (5-nitrofuryl-2) -pyridine
CS235196B1 (en) Method of 4,9-dihydro-3,9-dimethyl-4-oxo-1h-pyrazolo(3,4-b) quinoline
US3361749A (en) Certain n-pyrimidyl anthranilic acid derivatives
CZ299329B6 (en) Process for preparing 7-ethyl-10-[4-(1-piperidino)-1-piperidino]-carbonyloxy camptothecin
CA2370389A1 (en) Novel synthesis of piperazine ring
RU2104271C1 (en) Method of preparing substituted or unsubstituted 1,4- dehydro-4-oxo-2-or 3-quinolinocarboxylic acids
King et al. The Preparation of 2-Substituted Vinyl Quaternary Salts
JPH05255328A (en) Glyoxal-n2-acetylguanine adduct and its production
CS235183B1 (en) Method of 4,9-dihydro-3,9-dimethyl-4-oxo-1h-pyrazolo-(3,4-b)quinoline preparation
Petrow et al. 84. New syntheses of heterocyclic compounds. Part II. 2-Phenyl-3: 4: 6: 7-dibenzo-1: 5-naphthyridine
Stadlbauer et al. Thermal Cyclization of 3‐Acyl‐4‐azidopyridines to Isoxazolo [4, 3‐c] pyridines
US2673848A (en) 3-alkenylxanthines and their lower 1-alkyl derivatives
US2686781A (en) Pyrido (3, 2-d) pyrimidines and process of preparing same
US2442837A (en) Method of preparing heterocyclic organic compounds
US2698846A (en) Heterocyclic compounds
SU502605A3 (en) Method for preparing imidazole derivatives
US2437853A (en) Preparation of dihydroxanthopterin and xanthopterin
CS261338B1 (en) Method of 10-nitro-4-oxo-4h-quino/2,3,4-i,j/1,4/benzoxazine derivatives preparation
JPS5814438B2 (en) Pyrazolopyridine
PL65773B1 (en)
SU454739A3 (en) Method for preparing 5 (6) -acylbenzimidazolyl alkyl carbamates
PL188792B1 (en) Method of obtaining n-(2-hydroxyethyl) benzoanphtyridine bromides
JPS6256154B2 (en)
PL129505B2 (en) Process for preparing novel 2-beta-chloroethyl-8-hydroxy-9-benzoylaminoperhydropyrazin/1,2-c/pyrimidin-1,6-dione